The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era - 21/08/11
, Bryan Mulheron, B.S. a, Barbara A. Pockaj, M.D. a, Amy Degnim, M.D. b, Stephen L. Smith, M.D. c
Corresponding author. Tel.: +1-480-342-2849; fax: +1-480-342-2866.Abstract |
Background |
For patients with microinvasive breast cancer, the value of intraoperative analysis of sentinel lymph nodes (SLNs) and complete axillary lymph node dissection (CALND) is not well known.
Methods |
All patients staged T1mic from 2001 to 2005 were analyzed.
Results |
Among all 81 patients, 4 (5%) had SLN metastases detected with hematoxylin and eosin staining and 2 (2%) had metastases identified by immunohistochemistry staining only. Seventy-seven patients (95%) underwent SLN biopsy; 3 (4%) had hematoxylin and eosin SLN metastases and 2 (3%) had immunohistochemistry-detected metastases. One SLN metastasis was identified on frozen section analysis. No patient with a SLN metastasis had additional metastases on CALND. The patient charges for frozen section analyses were $39,578 for 77 patients. This prevented 1 reoperative CALND at a charge of $20,274.
Conclusions |
Frozen section analysis should be used only in select patients with microinvasive breast cancer and CALND is of limited value for these patients.
Le texte complet de cet article est disponible en PDF.Keywords : Breast cancer, Microinvasion, Ductal carcinoma-in-situ with microinvasion, Sentinel node, Frozen section analysis
Plan
Vol 194 - N° 6
P. 845-849 - décembre 2007 Retour au numéro
Article précédent
- Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series
- Cristiano G.S. Huscher, Andrea Mingoli, Giovanna Sgarzini, Gioia Brachini, Barbara Binda, Massimiliano Di Paola, Cecilia Ponzano
- Navigating murky waters: a modern treatment algorithm for nipple discharge
- Richard J. Gray, Barbara A. Pockaj, Patricia J. Karstaedt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?